Safety and Effectiveness of Insulin Detemir in Different Age-Groups in the A(1)chieve Study

INTRODUCTION: Diabetes therapy should balance glycemic control with risk of adverse events. This sub-analysis of the A(1)chieve study evaluated clinical safety and effectiveness of insulin detemir in different age-groups (≤40 years, >40–65 years, and >65 years) of insulin-experienced and insul...

Descripción completa

Detalles Bibliográficos
Autores principales: Malek, Rachid, Gonzalez-Galvez, Guillermo, El Naggar, Nabil, Shah, Siddharth, Prusty, Vinay, Litwak, Leon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687092/
https://www.ncbi.nlm.nih.gov/pubmed/23670204
http://dx.doi.org/10.1007/s13300-013-0021-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687092/
https://www.ncbi.nlm.nih.gov/pubmed/23670204
http://dx.doi.org/10.1007/s13300-013-0021-3

Ejemplares similares